Prognostic Impact of <i>KRAS</i> and <i>SMARCA4</i> Mutations and Co-Mutations on Survival in Non-Small Cell Lung Cancer: Insights from the AACR GENIE BPC Dataset

<b>Background/Objectives</b>: <i>KRAS</i> mutations are among the most prevalent oncogenic drivers in non-small cell lung cancer (NSCLC), with their impact on survival influenced by co-mutations. <i>SMARCA4</i> mutations are increasingly associated with poor prognosis and can be classified as class...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Peter Manolakos, Yu-Bo Wang, Janice Withycombe, Luigi Boccuto, Diana Ivankovic
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-09-01
Edice:	Biomedicines
Témata:	<i>KRAS</i> <i>SMARCA4</i> mutation co-mutation <i>KRAS</i>/<i>SMARCA4</i> NSCLC
On-line přístup:	https://www.mdpi.com/2227-9059/13/9/2142
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!